V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 4.39 USD 3.29% Market Closed
Market Cap: 173.4m USD

Intrinsic Value

The intrinsic value of one VTGN stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.39 USD, VistaGen Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

VTGN Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
VistaGen Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

VTGN looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if VTGN is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about VTGN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is VTGN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for VistaGen Therapeutics Inc.

Explain Valuation
Compare VTGN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VTGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
VistaGen Therapeutics Inc

Current Assets 78.9m
Cash & Short-Term Investments 77.2m
Other Current Assets 1.8m
Non-Current Assets 2m
PP&E 1.6m
Other Non-Current Assets 405k
Current Liabilities 13.6m
Accounts Payable 1.8m
Accrued Liabilities 9m
Short-Term Debt 658k
Other Current Liabilities 2.1m
Non-Current Liabilities 946k
Other Non-Current Liabilities 946k
Efficiency

Free Cash Flow Analysis
VistaGen Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
VistaGen Therapeutics Inc

Revenue
736k USD
Operating Expenses
-51.7m USD
Operating Income
-51m USD
Other Expenses
2.4m USD
Net Income
-48.6m USD
Fundamental Scores

VTGN Profitability Score
Profitability Due Diligence

VistaGen Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

VistaGen Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

VTGN Solvency Score
Solvency Due Diligence

VistaGen Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

VistaGen Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VTGN Price Targets Summary
VistaGen Therapeutics Inc

Wall Street analysts forecast VTGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTGN is 14.79 USD with a low forecast of 12.12 USD and a high forecast of 19.95 USD.

Lowest
Price Target
12.12 USD
176% Upside
Average
Price Target
14.79 USD
237% Upside
Highest
Price Target
19.95 USD
354% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

VistaGen Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VTGN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VTGN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VTGN stock?

The intrinsic value of one VTGN stock under the Base Case scenario is hidden USD.

Is VTGN stock undervalued or overvalued?

Compared to the current market price of 4.39 USD, VistaGen Therapeutics Inc is hidden .

Back to Top